Stockscreener 앱 받기
2.66%
시장 영업 전:
전일 마감가:
$198.54
열려 있는:
$200
하루 거래량:
849.57K
Relative Volume:
0.99
시가총액:
$13.08B
수익:
$13.84B
순이익/손실:
$1.10B
주가수익비율:
19.56
EPS:
10.4185
순현금흐름:
$1.49B
1주 성능:
+6.07%
1개월 성능:
+2.46%
6개월 성능:
+69.39%
1년 성능:
+47.52%
1일 변동 폭
$198.37
$205.42
1주일 범위
$190.43
$205.42
52주 변동 폭
$101.00
$205.42
다비타 Stock (DVA) Company Profile
명칭
Davita Inc
전화
310-536-2668
주소
2000 16TH STREET, DENVER, CO
Compare DVA vs HCA, THC, FMS, EHC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DVA
Davita Inc
|
203.83 | 12.74B | 13.84B | 1.10B | 1.49B | 10.42 |
HCA
Hca Healthcare Inc
|
378.51 | 82.82B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
173.17 | 14.19B | 21.46B | 2.65B | 3.35B | 19.23 |
FMS
Fresenius Medical Care Ag Adr
|
22.37 | 11.97B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
102.38 | 10.25B | 6.07B | 793.80M | 464.40M | 5.9914 |
다비타 Stock (DVA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-03-06 | 개시 | Barclays | Equal Weight |
| 2023-08-07 | 업그레이드 | UBS | Neutral → Buy |
| 2022-11-01 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2022-10-31 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-08-19 | 재개 | UBS | Buy |
| 2022-06-21 | 재확인 | BofA Securities | Underperform |
| 2021-09-10 | 개시 | Cowen | Market Perform |
| 2021-08-12 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2021-03-26 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2021-01-05 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-01-24 | 업그레이드 | Goldman | Neutral → Buy |
| 2019-11-07 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2019-10-25 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2019-09-11 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2019-07-26 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2019-01-08 | 업그레이드 | UBS | Sell → Neutral |
| 2019-01-03 | 개시 | Deutsche Bank | Buy |
| 2018-12-14 | 개시 | Barclays | Overweight |
| 2018-11-28 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2018-11-16 | 개시 | UBS | Sell |
| 2018-11-08 | 다운그레이드 | Raymond James | Strong Buy → Mkt Perform |
| 2018-09-13 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2018-01-04 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2017-12-12 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2017-12-11 | 업그레이드 | Citigroup | Neutral → Buy |
| 2017-12-07 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2017-11-08 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2017-10-09 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2017-06-26 | 다운그레이드 | Jefferies | Buy → Hold |
| 2016-12-13 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
모두보기
다비타 주식(DVA)의 최신 뉴스
DaVita, SCA, USPI defeat class certification bid in US no-poach litigation - MLex
DaVita HealthCare (DVA) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance
DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch
DaVita HealthCare (DVA) Moves to Strong Buy: Rationale Behind the Upgrade - Yahoo Finance
DaVita expands comprehensive kidney care through dialysis services - MSN
DaVita stock gains from integrated kidney care and CKCC progress - MSN
DaVita Stock Gains From Integrated Kidney Care and CKCC Progress - TradingView
Are Investors Undervaluing DaVita (DVA) Right Now? - Yahoo Finance
Zacks Industry Outlook Highlights Quest Diagnostics, DaVita, LifeStance Health and Aveanna Healthcare - Yahoo Finance
DaVita’s US$500 Million Term Loan Reshapes Debt And Liquidity Profile - Yahoo Finance
DaVita Inc. $DVA Stake Lifted by Los Angeles Capital Management LLC - MarketBeat
A Look at DaVita Inc (DVA) After 3.2% Gain -- GF Value $172.98 v - GuruFocus
DaVita Expands Term Loan Facility, Enhancing Capital Flexibility - The Globe and Mail
Best Growth Stocks to Buy for June 9th - Yahoo! Finance Canada
Best Value Stocks to Buy for June 9th - Yahoo Finance Singapore
DaVita Inc. (DVA) Announces Ninth Amendment to Credit Agreement - GuruFocus
DavitaEnters Ninth Amendment To Credit Agreement With Jpmorgan On June 8, 2026SEC Filing - TradingView
DaVita Secures $500 Million Incremental Term Loan B-2 Under Credit Facility With JPMorgan - TradingView
DaVita Inc. Enters into Ninth Amendment to Credit Agreement for $500 Million Incremental Tranche B-2 Term Loan - marketscreener.com
DaVita Inc. (DVA) Maintains Strong Buy Rating for 120 Days - GuruFocus
MOTheR Trial: Advancing Middle-Molecule Clearance - DaVita Newsroom
Bull of the day: DaVita Inc. (DVA) - MSN
Asset turnover of DaVita Inc. – XETR:TRL - TradingView
Cash per share of DaVita Inc. – XETR:TRL - TradingView
Long term debt to total assets ratio of DaVita Inc. – XETR:TRL - TradingView
EBITDA per share of DaVita Inc. – XETR:TRL - TradingView
DaVita Inc. Cash Flow – XETR:TRL - TradingView
DaVita Inc. Statistics – XETR:TRL - TradingView
Assessing DaVita (DVA) Valuation After Strong Q1 2026 Beat And Upgraded Guidance - Yahoo Finance
Nomura Asset Management Co. Ltd. Sells 16,576 Shares of DaVita Inc. $DVA - MarketBeat
Why is DaVita HealthCare Partners stock surging today? - Investing.com
DaVita Inc stock (US23804L1035): Q1 2026 revenue tops estimates while valuation stays in focus - AD HOC NEWS
BofA raises DaVita stock price target to $145 on Q1 beat - Investing.com
DaVita Q1 2026 Earnings: Outpatient and Specialty Care Sector ReviewNews and Statistics - IndexBox
Q1 Earnings Highs And Lows: DaVita (NYSE:DVA) Vs The Rest Of The Outpatient & Specialty Care Stocks - Yahoo Finance
DaVita (DVA) Short Interest & Short Float | Updated Jun 2026 $DVA - MarketBeat
Why is DaVita HealthCare Partners stock surging today? By Investing.com - Investing.com UK
DaVita Inc. stock underperforms Thursday when compared to competitors - MarketWatch
The Sound of a Second Chance: DaVita Patients Celebrate Receiving Their Kidney Transplant - DaVita Newsroom
DaVita Expands Comprehensive Kidney Care Through Dialysis Services - Yahoo Finance
DaVita HealthCare (DVA) Up 0.6% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Best Growth Stocks to Buy for June 4th - Yahoo Finance Singapore
A Look at DaVita Inc (DVA) After 3.8% Gain -- GF Value $172.69 v - GuruFocus
A Look at DaVita Inc (DVA) After 3.8% Gain -- GF Value $172.69 vs Price $195.03 - GuruFocus
How The DaVita (DVA) Story Is Shifting With New Analyst Targets And Valuation Assumptions - Yahoo Finance
DaVita Gains 21.4% in Three Months: How Should You Play the Stock? - TradingView
What are Wall Street analysts' target price for DaVita stock? - MSN
1 Sector Warren Buffett and Greg Abel Are Largely Ignoring -- and Why Investors Shouldn't - The Motley Fool
DaVita Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
DaVita Inc. stock underperforms Monday when compared to competitors - MarketWatch
DaVita Inc. stock (US23918K1088): NYSE-listed dialysis provider trades around late-May levels as inv - AD HOC NEWS
다비타 (DVA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.40%
0.94%
자본화:
|
볼륨(24시간):